Randomized Controlled Trials of Pediatric Massage: A Review by Beider, Shay & Moyer, Christopher A.
Advance Access Publication 3 November 2006 eCAM 2007;4(1)23–34
doi:10.1093/ecam/nel068
Review
Randomized Controlled Trials of Pediatric Massage: A Review
Shay Beider
1 and Christopher A. Moyer
2
1Integrative Touch for Kids, Beverly Hills, CA and
2University of Illinois at Urbana-Champaign, Urbana,
IL 61801-4819, USA
The existing reviews of massage therapy (MT) research are either limited to infants, adults, or were
conducted prior to the publication of the most recent studies using pediatric samples. Randomized
controlled trials (RCTs) of pediatric MT are reviewed. A literature search yielded 24 RCTs of pediatric
MT, defined as the manual manipulation of soft tissue intended to promote health and well-being in
recipients between 2 and 19 years of age. Because RCTs of pediatric MT varied considerably in the
amount and types of data reported, quantitative and narrative review methods were both used. Single-
dose and multiple-dose effects were examined separately. Among single-dose effects, significant
reductions of state anxiety were observed at the first session (g ¼ 0.59, P < 0.05) and the last session
(g ¼ 1.10, P < 0.01) of a course of treatment. Effects for salivary cortisol (g ¼ 0.28), negative mood
(g ¼ 0.52) and behavior (g ¼ 0.37) were non-significant. Three of eleven multiple-dose effects
were statistically significant. These were trait anxiety (g ¼ 0.94, P < 0.05), muscle tone (g ¼ 0.90,
P < 0.01) and arthritis pain (g ¼ 1.33, P < 0.01). Results of studies not permitting effect size calculation
were judged to be generally consistent with quantitative results. MT benefits pediatric recipients,
though not as universally as sometimes reported. Numerous weaknesses endemic to MT research
(e.g. low statistical power, frequent failure to report basic descriptive statistics) are identified, and
recommendations for future pediatric MT research are discussed.
Keywords: CAM – child – comfort – health care – integrative medicine – kid – pain management –
quality of life – touch
Introduction
Background
Massage therapy (MT) is one of the most widely used
complementary and alternative medicine (CAM) therapies in
the United States according to National Health Interview
Survey data. It is estimated that consumers spend between
2 and 4 billion dollars on 75 million visits to massage
therapists annually (1). Studies indicate that parents are
making increasing use of CAM therapies, including MT, for
their children. One study found that 33% of parents reported
using CAM for their child within the past year, with MT being
one of the most popular therapies (2). Another study shows
that families of children with special health care needs are
almost twice as likely to have used CAM for their child (3).
CAM use is now prevalent, even in many traditional medical
settings [e.g. 49% of university-affiliated pain management
centers in the US and Canada offer MT (4)], yet pediatricians
and other health care professionals are often not informed
about the CAM therapies that are being used by their patients
(2). This may be especially true for pediatric CAM, where
survey results indicate that 81% of parents currently using
CAM for their child wanted to discuss it with their
pediatrician, but only 36% did (5). For CAM to truly be
integrated into the health care system, it needs to be openly
discussed and recognized for its value, particularly in the
area of palliative care (6). A scientific understanding of
CAM therapies, such as pediatric MT, will permit a greater
understanding of the value of this type of therapy.
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been conducted. These include randomized controlled trials
(RCTs), evaluation studies, descriptive case studies and
reviews. However, the existing reviews of MT research are
either limited to adult participants, limited to infants, were
conducted prior to the publication of the most recent studies
using pediatric samples, or neglected to quantify results.
Ottenbacher and colleagues (7) quantitative review of tactile
stimulation for infants and young children, published nearly
20 years ago, found statistically significant beneficial out-
comes for five of the six categories examined (these were
motor/reflex, cognitive/language, social/personal, physiologi-
cal and overall development; visual/auditory was non-
significant). Field (8) conducted a narrative review, including
research on persons of all ages, and concluded that MT had a
multitude of condition-specific effects in addition to consis-
tently providing reductions of anxiety, depression and levels of
stress hormones (most notably cortisol) that were observed
across studies. The two most recent reviews are quantitative
reviews that focus specifically on either infants or adults. A
Cochrane review systematically examines MT for preterm and
low birth-weight infants, and reaches the negative conclusion
that ‘there is insufficient evidence of effectiveness to warrant
wider use of preterm infant massage’ (9). The quantitative
review of MT performed on adults confirmed (and quantified)
some of Field’s conclusions while disputing others (10).
Substantial reductions resulting from multiple sessions of MT
were noted for depression (g ¼ 0.62, P < 0.01) and trait anxiety
(g ¼ 0.75, P < 0.01), while MT’s effect on cortisol levels was
not statistically significant (g ¼ 0.14). While this review
supported the value of MT by quantifying its ability to
substantially reduce symptoms of psychological distress in
adults, taken together this set of findings called into question
some of the theories most often invoked to explain the benefits
of MT, especially the theory that MT benefits recipients
primarily by activating the parasympathetic nervous system (10).
Current Review
While the latest quantitative reviews increase our understand-
ing of MT and indicate new directions for research, they
neglect MT performed on pediatric samples. The current
review examines MT’s effects in pediatric samples (defined
here as studies where the mean age of participants was
between 2 and 19 years), with a focus on RCTs. While some
have argued against using RCTs to understand CAM
modalities such as MT (11), RCTs represent the state-of-the-
art for establishing cause and effect relationships in treatment
research because they are the most effective study design for
ruling out alternate (i.e. non-treatment) explanations for
observed effects, including spontaneous recovery, placebo
effects and statistical regression (12).
Though there have been some new pediatric MT studies
published since the reviews by Ottenbacher et al. (7) and Field
(8), the number of RCTs that examine pediatric MT is still
quite small. In addition, a weakness of existing MT research is
that, more often than not, studies in this area do not include the
minimal statistical detail necessary to calculate effect sizes.
For these reasons, a full meta-analytic treatment of MT
research with pediatric samples is not possible. However,
consistent with Rosenthal’s observation that a narrative
literature review can only be improved by the addition of a
simple, descriptive quantitative analysis (13), we quantified
results where possible, and include these results in combina-
tion with a narrative review of other RCTs. In some cases, the
present findings are being compared with analogous findings
in the adult literature. When these comparisons are made, we
are referring to the adult meta-analysis conducted by Moyer
et al., unless otherwise stated (10).
Operational Definition
A notable challenge in reviewing MT studies is that there are
many forms of MT in practice. The American Massage
Therapy Association (AMTA) defines massage as ‘manual
soft tissue manipulation, [including] holding, causing move-
ment, and/or applying pressure to the body’ (14). As written,
this very broad definition includes numerous MT approaches
commonly used in clinical practice that are relevant to the
current review, but could also include rare forms of medical
massage (e.g. optic nerve massage (15), light compressive
massage for congenital dacryocystocele (16), cardiac massage
(17)), that are outside the intended scope of this review. For
this reason, we focus on forms of MT that are consistent with
traditional Swedish styles of massage. Swedish massage uses
five main strokes to stimulate the circulation of blood through
the body; petrissage (kneading), effleurage (stroking), friction,
tapotement (tapping) and vibration. For the purposes of this
review, MT is typified by the manual manipulation of soft
tissue, performed by a person other than the recipient,
intended to promote health and well-being. This operational
definition allows a range of MT styles to be included in this
review. Studies vary on many details, including the amount of
clothing worn by recipients, whether a massage chair or
massage table was used, whether MT took place in a clinical
setting or at home, and whether MT was performed by a person
with full, partial, or no training as a massage therapist. Studies
also vary in which anatomical regions are massaged. Despite
all these variations, it is reasonable to expect that there will be
some consistent outcomes that result from MT. Eventually, as
a scientific understanding of MT grows, studies that examine
the importance of these variations will be advisable, but
currently the questions of greatest interest are at a more
fundamental level.
Types of Effects
MT effects can be divided into single-dose and multiple-dose.
Single-dose effects include MT’s influence on psychological
or physiological states that are transient in nature and that
might reasonably be expected to be influenced by a single
session of MT. Multiple-dose effects are restricted to MT’s
influence on variables that are considered to be more enduring,
24 Pediatric massage reviewor that would likely be influenced only by a series of MT
sessions performed over a period of time, as opposed to a
single dose. Frequently, both single- and multiple-dose effects
are examined in the same study. One example is a study of MT
for autistic children that examined the single-dose effect of
MT on salivary cortisol (immediately prior to, and immedi-
ately following, an individual session of MT) and the multiple-
dose effect of MT on depression (at the beginning of, and at
the conclusion of, a sequence of MT sessions over time) (18).
A second example is a study that evaluated children’s distress
during burn treatment, which included the single-dose effect of
MT for state anxiety and the multiple-dose effect of MT for
depression (19). Typically, studies include the terms ‘short-
term effect’ and ‘long-term effect’ to indicate single- and
multiple-dose effects, respectively. Our decision to use the
single-dose and multiple-dose terminology is motivated by the
desire to prevent any confusion that may arise related to how
long an effect may last following the termination of treatment.
None of the studies in the current review examine whether any
MT effects last beyond the final day on which a participant
receives treatment, making the use of the term ‘long-term
effect’ potentially misleading.
The potential benefits of MT can be further classified
according to whether they are primarily affective, physiolo-
gical or behavioral in nature. Affective refers to effects most
closely associated with the recipients’ feelings and emotions.
Physiological effects are those concerned with recipients’ vital
organismic processes. Behavioral effects are those related to
the recipients’ observable responses to their environment.
Study results reviewed here will first be separated by the
single-dose versus multiple-dose distinction, then further
categorized into affective, physiological and behavioral
dimensions.
Methods
Literature Search
A literature search was conducted by the first author (S.B.)
using the keywords massage, child and pediatric to search the
MEDLINE, LexisNexis, CINAHL and PsycInfo databases.
We checked the NIH CRISP Database to search for other
publicly funded studies currently in progress. MT researchers
were also contacted to obtain studies that were unpublished, in
press or otherwise not found by means of database searches.
With the introduction of the first Massage Therapy Research
Conference in Albuquerque, New Mexico (43), leaders in the
field of massage research were readily contacted. We used this
opportunity to access current unpublished pediatric massage
studies. Studies obtained by these methods were inspected to
ensure that they examined a form of MT consistent with the
present study’s operational definition of MT performed on a
pediatric sample. Application of these criteria yielded 24
RCTs of MT with a pediatric sample. These studies, along with
important details, are listed in Table 1.
Statistical Analysis
For studies that provided sufficient data, between-groups
comparisons on variables of interest were converted to
Hedges’ g effect size by the second author (C.A.M.). Hedges’
g, calculated as (Group mean 1   Group mean 2)/Pooled SD,
estimates the number of standard deviations that the average
member of a treatment group differs from the average member
of a comparison group for a given outcome. Hedges’ g was
selected over Cohen’s d, a similar standardized mean
difference effect size. This choice was made for two reasons.
First, in some cases the original study data could only be
converted to g. Second, using g makes the results of the current
review as consistent as possible with the existing meta-
analysis of MT effects for adults.
In cases where a study employed more than one measure to
examine the same outcome variable, results of multiple
measures completed by participants or by blinded observers
(but not those completed by non-blind observers) were
standardized and then averaged, yielding one effect size per
variable for each study. Similarly, if a study examined the
immediate effects of more than one application of treatment,
the results of the multiple applications or assessments were
standardized and, when similar in magnitude, averaged in
order to calculate a single effect size for that study. In the
single case where these assessments clearly differed in a
systematic way (i.e. state anxiety, where the effects of a final
session were always larger than the effects of the initial
session; paired sample t(3) ¼ 4.46, one-tailed P < 0.02),
separate effects were calculated for each timepoint. Effect
sizes were coded such that positive values, for any variable,
indicate a more desirable outcome (e.g. a reduction in anxiety)
for the participants who received MT. Individual study effect
sizes were subjected to a correction for small sample bias, then
weighted by their inverse variance and averaged to generate a
mean effect size for each outcome variable (20). All effect
sizes were calculated according to a random effects model of
error estimation. Statistical significance of the mean effect
sizes was assessed by calculating the 95% confidence interval
for the population parameter. A significance level of 0.05 or
better is inferred when zero is not contained within the
confidence interval.
Results
Of the 24 RCTs, only 9—accounting for a total of 200
participants—provided sufficient data for their results to be
systematically quantified. Table 2 lists mean effect sizes for 16
outcome variables (g), as well as the number of studies
contributing to each effect size (k), the total number of
participants contributing to each effect size (N) and 95%
confidence intervals. Five of these sixteen effect sizes were
statistically significant. For the single-dose effects category,
these included state anxiety at the first session (g ¼ 0.59, P <
0.05) and at the last session (g ¼ 1.10, P < 0.01) of a course
of treatment. Effects for salivary cortisol (g ¼ 0.28),
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eCAM 2007;(4)1 27negative mood (g ¼ 0.52) and behavior (g ¼ 0.37) were non-
significant. Only 3 of the 11 multiple-dose effect sizes were
statistically significant. These were trait anxiety (g ¼ 0.94, P<
0.05), arthritis pain (g ¼ 1.33, P < 0.01) and muscle tone (g ¼
0.90, P < 0.01).
Of the 24 RCTs, 15 (accounting for 458 research partici-
pants) do not report sufficient data to permit effect size
calculation, a frequent problem in MT research that makes
objective interpretation of results difficult. Nevertheless, by
judiciously comparing the scant data presented in this subset of
studies with the objective data previously summarized, it
should be possible to see if there are any dramatic contrasts
among the findings. These interpretations, within the context
of the more objective findings, appear in the results categories
that follow.
Single-Dose Effects
Affective Dimension
State anxiety. Field et al. have conducted several pediatric MT
studies where anxiety is an outcome measure. These studies
date back to 1992 when MT was applied to a group of pediatric
psychiatric patients (21). Four studies with reportable effect
sizes (No.’s 6, 14, 17 and 21 in Table 1), using a total of 81
participants, compared MT with either relaxation therapy or a
reading comparison group with state anxiety—a momentary
emotional reaction consisting of apprehension, tension, worry
and heightened autonomic nervous system activity (22)—as a
dependent variable. Three of the studies (No.’s 14, 17 and 21)
used the State Trait Anxiety Inventory (two specify the child
version). One study (No. 6) of MT for children with juvenile
rheumatoid arthritis used a behavior observation of the child’s
anxiety level performed by a blinded rater. MT consistently
reduced state anxiety in these studies. This single-dose effect
was unique in that it is significantly larger at the second
timepoint, so we examined these separately. Results of a first
session of MT yield a statistically significant effect, g ¼ 0.59
(95% CI ¼ 0.15, 1.04). The effect at the last session is even
greater, g ¼ 1.10 (95% CI ¼ 0.64, 1.57). These results are
depicted graphically in Fig. 1. Possibly, the substantially larger
effect occurring at the last session of treatment may be the
result of participants’ increasing comfort with MT (or with the
massage therapist) over the course of time, or the effect may be
related to MT’s potential to reduce trait anxiety over a course
of treatment (8). These pediatric results are consistent with the
same effect found for adults, where this effect has been
estimated as g ¼ 0.37 (95% CI ¼ 0.14, 0.59). Possibly, the
larger effect for the pediatric samples examined here reflects a
greater treatment aptitude for this population; however, with
such wide confidence intervals, this is only speculation.
Studies where state anxiety was a dependent variable but
effect sizes could not be calculated include samples of children
who experienced Hurricane Andrew (23), depressed adoles-
cent mothers (24), and children and adolescents with a range of
illnesses including diabetes (25), atopic dermatitis (26),
asthma (27), bulimia (28) and leukemia (29). The most
commonly used measures across these studies were the State
Trait Anxiety Inventory for Children (STAIC) and the State
Trait Anxiety Inventory (STAI) for adolescents. A study of
children who experienced Hurricane Andrew assessed both the
single-dose effects of state anxiety and the multiple-dose
effects of trait anxiety. These studies are consistent with the
previously reported effect sizes, in that MT appears to decrease
state anxiety. The MT in all of these studies was conducted
either daily or twice weekly over a treatment period of 30–45
days. MT sessions generally lasted between 20 and 30 min, the
one exception being the leukemia study where MT sessions
were 15 min in duration. Four of these studies trained parents
to provide MT directly to their child and the remaining three
either used trained massage therapists or massage students.
Mood. Mood, which may be defined as ‘transient episodes of
feeling or affect’ (30), has frequently been an outcome
measure in pediatric MT studies. Study populations have
included depressed adolescent mothers, and children and
adolescents with cystic fibrosis, leukemia and bulimia. Two
studies (No.’s 13 and 14 in Table 1), using a total of 50
participants, compared MT with either a reading or wait-list
control to examine MT’s effect on mood. One of these studies
(No. 14) used the Profile of Mood States (POMS) (31)
depressed mood subscale. The second study (No. 13) used a
faces scale and a modification of the Children’s Pain/Fear
Thermometer Rating Scale. Taken together, these studies yield
a non-significant effect, g ¼ 0.52 (95% CI ¼  0.05, 1.10)
that is consistent with the results found for adult recipients
(g ¼ 0.34, 95% CI ¼  0.08, 0.76). These positive but
Table 2. Mean effect sizes (g) by outcome variable
Outcome variable kN g 95% CI
Single-dose effects
State anxiety, first session 4 81 0.59* 0.15, 1.04
State anxiety, last session 4 81 1.10** 0.64, 1.57
Negative mood 2 50 0.52  0.05, 1.10
Salivary cortisol 2 50 0.28  0.27, 0.84
Behavior 1 24 0.37  0.43, 1.35
Multiple-dose effects
Depression 2 54 0.48  0.06, 1.02
Trait anxiety 1 30 0.94* 0.20, 1.68
Arthritis pain 1 20 1.33** 0.37, 2.29
Muscle tone 2 41 0.90** 0.23, 1.57
Range of motion 1 20 0.31  0.57, 1.19
Immune measures 2 48 0.06  0.52, 0.63
Pulmonary function 1 20 0.47  0.41, 1.35
Developmental functioning 2 41 0.24  0.38, 0.86
Spasticity 1 20 0.26  0.62, 1.14
Hostility 1 17  0.85  1.85, 0.15
Classroom behavior 1 30 0.66  0.07, 1.39
Note: A positive g indicates a reduction for any outcome variable.
CI, confidence interval.
*P < 0.05. **P < 0.01.
28 Pediatric massage reviewnon-significant results suggest at least four possibilities. One is
that the tools that have been used to measure mood in these
studies are not precisely capturing overall mood, but are being
affected by correlates of mood such as depression, pain or fear.
A second possibility is that MT’s modest effect on mood has
not been examined with sufficient statistical power, resulting
in wide confidence intervals. The third is that MT’s positive
effect on mood is affected by a moderator variable that has not
yet been examined (e.g. recipient’s comfort with MT; the
existence of a therapeutic bond between the recipient and
provider, etc.). Finally, the possibility that MT does not
specifically have a positive effect on mood cannot be
definitively ruled out.
Physiological Dimension
Salivary cortisol. Two studies (No.’s 6 and 13 in Table 1),
using a total of 50 participants, compared MT with either
relaxation training or a wait-list control to examine MT’s
single-dose effect on cortisol—a stress hormone associated
with activation of the sympathetic nervous system in response
to certain kinds of stressors. In both studies, salivary cortisol
[but not urinary cortisol, which less accurately captures short-
term stress responses (32) most likely to respond to single-dose
MT] was sampled pre- and post-MT session, with a delay of
20–30 min after the session, because salivary cortisol samples
reflect responses to stimulation occurring  20 min prior to
collection. Both studies also took into account the diurnal
cortisol cycle, characterized by an increase in secretory
activity following awakening and a declining trend over the
course of the day (33). Combined, these studies yield a non-
significant reduction, g ¼ 0.28 (95% CI ¼  0.27, 0.84)
of salivary cortisol for the participants receiving MT in
comparison to controls. This finding contrasts Field’s assertion
that reductions in cortisol level are one of MT’s most reliable
effects, but is consistent with meta-analytic findings based
on adult samples, where cortisol effects were small and non-
significant (g ¼ 0.14, 95% CI ¼  0.10, 0.38) (10). Based on
the available evidence, MT’s single-dose effect on cortisol
levels appears to be small, and possibly zero.
Behavioral Dimension
Distress behaviors. One study (No. 20 in Table 1) compared
MT with standard care for children receiving burn treatment,
and examined the children’s distress behaviors before and
during this painful procedure. The Children’s Hospital of
Eastern Ontario Pain Scale (34) was used to code distress
behaviors before and during a dressing change (35). Six
behavior categories were assessed including cry, facial,
verbal, torso, touch and legs. The MT group showed only an
increase in torso movements during the dressing change,
whereas the control group showed an increase in five out of the
six distress behaviors. Combined observational ratings made
by nurses, who were blind to the group to which the children
were assigned, favored MT, g ¼ 0.37 (95% CI ¼  0.43, 1.17).
Though this effect favors MT, the wide confidence interval,
which may be partially or wholly attributable to the small
sample (n ¼ 24), makes this result difficult to interpret.
In several other studies with behavioral outcomes where
effect sizes could not be calculated, researchers reported
improvements in fidgetiness, activity, vocalization and coop-
eration. The most commonly used instrument in these studies
is a Behavior Observation Scale that was first used to assess
Figure 1. Single-dose effects (g and 95% CI) of MT on state anxiety obtained at first sessions and last sessions of treatment.
eCAM 2007;(4)1 29behavior after relaxation therapy classes (36). Using this
measure, behavior is observed three times during the 30 min
prior to MT, during MT itself and during the 30 min after MT.
Because the effect size data are inconclusive and researchers
report positive behavioral improvements resulting from MT,
further study on distress behaviors may be warranted.
Multiple-Dose Effects
Affective Dimension
Depression. Depression, including motivational and cognitive
deficits, vegetative signs, and disruptions in interpersonal
relationships beyond those expected from ordinary unhappi-
ness or poor mood (37), has been examined in pediatric MT
studies, albeit with small samples. Two studies (No.’s 13 and
17 in Table 1), using a total of 54 participants, examined
whether MT would reduce depression in comparison to either a
wait-list control or to progressive muscle relaxation. The first
study (No. 13) used the Children’s Depression Inventory-Short
Form, and was the only study reviewed to use that measure. It
is an abbreviated version of a widely used self-report measure
of depression for children and adolescents. The second study
(No. 17) used the Center for Epidemiological Studies-
Depression scale, which was also used in several studies that
did not permit effect size calculation. Though the mean effect
favored MT, g ¼ 0.48, this effect is not statistically significant
(95% CI ¼  0.06, 1.02). This result is inconclusive, but
promising given that the confidence interval approaches
significance, and also because the estimated effect is not
greatly different from statistically significant reductions of
depression found in adult samples (g ¼ 0.62, 95% CI ¼ 0.37,
0.88). It is also generally consistent with the conclusions
reached by the authors of studies that did not permit effect size
calculation. Still, the possibility that MT does not reduce
depression for pediatric recipients to the extent it does in adults
cannot be ruled out. At this point, further study on MT for
pediatric depression is needed.
Trait anxiety. One study (No. 13 in Table 1), using a sample
of children and adolescents with attention-deficit hyperactivity
disorder, examines MT’s effect on trait anxiety, a disposi-
tional, internalized proneness to be anxious (38), with enough
detail to permit effect size calculation. This study, which also
appears in the adult MT meta-analysis, uses the Revised
Children’s Manifest Anxiety Scale to compare MT with a
wait-list condition and yields a large, statistically significant
effect (g ¼ 0.94, 95% CI ¼ 0.20, 1.68) that is consistent MT’s
anxiolytic effects demonstrated in numerous studies with adult
recipients. This result is consistent with author claims in the
‘Hurricane Andrew’ study, where improvements in children’s
trait anxiety at the end of the MT treatment are reported.
Reduction of trait anxiety, resulting from a course of MT
sessions, is certainly worthy of further study in pediatric
populations.
Pain. Four pediatric studies have been conducted that
include pain as an outcome measure. Three of these studies
used the Happy Faces Scale while only one study, a study of
children with juvenile rheumatoid arthritis (and the only study
with sufficient data for calculating effect sizes), used the
Varni/Thompson Pediatric Pain Questionnaire. This study
(No. 6 in Table 1) assessed pain in three ways—child self
report, parent report and physician report. The children and a
pediatric rheumatologist, who was blind to group assignment,
generated reports of pain reduction that were consistent;
parents’ ratings were omitted from effect size calculation due
to their non-blind status and proneness to bias. In comparison
to a relaxation therapy group, MT yielded a large, statistically
significant pain reduction (g ¼ 1.33, 95% CI ¼ 0.37, 2.29).
This very large effect, in contrast with other studies that have
shown mixed results for pain reduction resulting from MT,
suggests that MT may be particularly well-suited to pain
reduction for children with this condition.
Three RCT’s that do not permit effect size calculation
looked at MT’s impact on pain, and concluded that children
experienced reductions of pain resulting from MT. Samples
in these studies included children who experienced Hurri-
cane Andrew (23), adolescents with attention-deficit hyper-
activity disorder (39) and children with atopic dermatitis
(26). These reports, combined with the findings in the
juvenile rheumatoid arthritis study, indicate that MT for pain
reduction in pediatric recipients is worthy of further
examination.
Physiological Dimension
Muscle tone. Two recent studies that assess muscle tone
(No.’s 23 and 24 in Table 1) yield g ¼ 0.90 (95% CI ¼ 0.23,
1.57). The first examines MT for children with cerebral palsy
who received 30 min of MT 2 times per week for 12 weeks.
This study also assesses spasticity, motor functioning, facial
expressions and limb activity. The second study, of children
with Down syndrome provided 30 min of MT 2 times per week
for 8 weeks. Children’s development, and fine and gross motor
functioning, was evaluated. Both studies used the Arms, Legs
and Trunk Muscle Tone Scale (ALT Muscle Tone Scale),
which was designed during the pilot phase of the Down
syndrome study. There is modest support that MT improves
muscle tone, though it must be pointed out that the two studies
diverge greatly in their individual results. Study number 23
in Table 1 had virtually no effect, while study number 24 had
a huge effect. It must be noted that because these results come
from a newly developed measure, the validity of the measure is
not yet well-established. This may account for the divergent
results across studies.
Range of motion. One study (No. 23 in Table 1), with a
sample of children suffering from cerebral palsy, yields non-
significant improvements in range of motion, g ¼ 0.31 (95%
CI ¼  0.57, 1.19). The study notes that right and left hip
extension, but not abduction, improved. Study authors note
that increased muscle tone may have led to an increase in
range of motion, but this result, based on a single study with
20 participants, is inconclusive.
30 Pediatric massage reviewImmune measures. Two studies (No.’s 17 and 22 in Table 1)
examined markers of immune system functioning in HIVþ
adolescents or children. Though study authors are quick to
point out that there were some within-group effects for those
who received MT, a between-groups analysis that compares
MT recipients with controls yields no effect (g ¼ 0.06, 95%
CI ¼  0.52, 0.63). In light of this result, specific MT effects
on CD4 count were then examined separately, to account for
the fact that the numerous immune system markers reported in
those studies, and combined in the process of effect size
calculation, might be obscuring this most important measure of
disease progression in HIVþ persons. When an effect size for
CD4 count only is generated from these two studies, the effect
is only marginally larger and still non-significant (g ¼ 0.24,
95% CI ¼  0.33, 0.82). Though these studies, and another
study of MT for children with leukemia (29), make much of
within-groups MT effects on immune system markers, the
available between-groups data show that MT’s effect on
immune system function is probably small and possibly zero.
Pulmonary function. One study (No. 14 in Table 1)
examined whether MT might generate an improvement in
peak air flow fora sample of 20 children with cystic fibrosis. In
comparison to a reading control group, the children receiving
MT had higher peak air flow, g ¼ 0.47 (95% CI ¼  0.41,
1.35), indicating MT may be of specific value to children with
this condition. Another study (27) that does not permit effect
size calculation reports multiple measures of breathing
improvement for asthmatic children ages 6–8 years, though
older children (ages 9–14 years) showed fewer improvements.
Overall, evidence for MT effects on pulmonary function is
promising, and further study is warranted.
Skin condition. Two RCT’s examine MT’s effect on skin
condition. Children with atopic dermatitis were studied to
determine the effect of MT on redness, scaling, lichenification,
excoriation and pruritus (26). Though effect sizes cannot be
calculated, study authors indicate some improvement follow-
ing MT. Pediatric patients with hypertrophic scarring (HTS)
were also studied and vascularity, pliability and height of the
HTS revealed no appreciable effects. There is some evidence
that pruritis decreased in certain patients with mature burn
scars following MT. There is insufficient evidence to validate
MT effects on skin condition in pediatric recipients.
Glucose level. (No. 7 in Table 1) One study of children with
diabetes examined the effect of MT on blood glucose levels
(25). The authors conclude that MT lowers mean blood
glucose levels and that compliance for insulin and food
regulation improved, though data necessary for effect size
calculation are not reported.
Behavioral Dimension
Developmentally appropriate functioning. Two studies
(No.’s 23 and 24 in Table 1) used the Developmental
Programming for Infants and Young Children (DPIYC)
scale to assess developmentally appropriate functioning in
recipients following MT. The average effect was small and
non-significant (g ¼ 0.24, 95% CI ¼  0.38, 0.86), though it
must be pointed out that the studies had divergent results.
Study number 24 yields a modest improvement in devel-
opmentally appropriate functioning in a sample of children
with Down syndrome. Study number 23, with a sample of
cerebral palsy sufferers, yields no effect. Possibly, these
divergent results are the result of the different populations
sampled within the studies. Taken together these results are
inconclusive, but the encouraging results of the study with
children who have Down syndrome indicate that further
studies should be done with children having this or a related
condition.
Spasticity. One study (No. 23 in Table 1), with a sample
of children suffering from cerebral palsy, examined whether
MT had an effect on spasticity by using the Spasticity
scale/modified Ashworth scale. The small, non-significant
effect (g ¼ 0.26, 95% CI ¼  0.62, 1.14) does not support
an MT effect on spasticity. Because this study was very small
(n ¼ 20), further testing in this area may be beneficial.
Hostility. One study (No. 21 in Table 1), with a small sample
of aggressive adolescents, examined whether MT might
reduce hostility compared with relaxation therapy. This study
yields g ¼  0.85 (95% CI ¼  1.85, 0.15), a non-significant
effect, but one that almost reaches significance in the wrong
direction. The most tenable conclusion from this finding, a
result based on a very small sample, is that MT has no effect on
hostility beyond that provided by relaxation therapy to which it
was compared. Though participants were randomly assigned,
the MT group was approximately three points higher on the
SCL-90R Hostility subscale prior to treatment. While scores
decreased in the MT group during the treatment period, they
also did in the relaxation therapy group, such that the MT
group is still three points higher than the relaxation therapy
group at the end of the treatment period. The authors’ assertion
that ‘by the end of the study [massaged adolescents] reported
feeling less hostile’ obfuscates the fact that there was no
between-groups effect. Related measures used in this study,
such as the Overt Aggression Scale, were completed not by
study participants, but by their legal guardians who were not
blinded to group assignment, making their ratings prone to
bias. Nevertheless, when all such measures included in the
study are used to calculate an effect size, regardless of
blinding, the result still converges on no effect.
Classroom behavior. One study (No. 13 in Table 1)
examined the classroom behavior of students with attention-
deficit hyperactivity disorder using the Conners Teacher
Rating Scale. Six factors of this scale were used including
hyperactivity, conduct, emotional-indulgent, anxious-passive,
asocial and daydream/attention problems. In comparison with
a wait-list control, MT yielded g ¼ 0.66 (95% CI ¼  0.07,
1.39), an effect that, while non-significant, is encouraging.
Further studies of MT for this population are needed to
confirm whether it might be of value in improving behavior,
an outcome that seems possible given MT’s relatively
well-established potential to reduce anxiety. Studies that
do not permit effect size calculation also suggest some
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MT. Improved classroom behavior and social relatedness are
reported in studies of preschool children (40) and children with
autism (41).
Cognitive performance. (No. 11 in Table 1) A study of MT
for children in preschool concludes that MT impacts cognitive
performance (42). This study used three subtests of the
Wechsler Preschool and Primary Scale of Intelligence—
Revised, but does not report sufficient data to quantify the
effect.
Sleep and relaxation. (No.’s 1, 2 and 18 in Table 1) Though
none permit effect size calculation, three studies have
examined the effect of MT on sleep and relaxation. In one
study, parents of children with autism recorded their children’s
sleep behavior in sleep diaries that included 5-point Likert
scales (41). It is reported that the MT group showed decreases
in fussing/restlessness, crying, self-stimulation behavior and
getting out of bed. Nighttime sleep recordings were conducted
for a previously mentioned study of MT for child and
adolescent psychiatric patients (21). A video camera was set
up on a tripod in the participant’s room. The video tapes were
subsequently coded for quiet sleep, active sleep, awake and
lying quietly, and awake and active. Percentage of time asleep
increased significantly from the first to last day of MT and the
percentage of nighttime wakefulness decreased over the same
time frame. Finally, children who experienced Hurricane
Andrew were rated by an observer on a visual analogue scale
(VAS), based on the child’s apparent relaxation level (23). The
VAS relaxation score increased significantly from the first to
the last day of MT for the MT group. Possibly, MT promotes
sleep and relaxation, but current studies do not permit this
effect to be quantified.
Discussion
Available data reveals that MT provides benefit to pediatric
recipients, though not as universally as has sometimes been
reported. Benefits from both single-dose and multiple-dose
sessions are evident. Most of the statistically significant effect
sizes were observed for affective outcomes; findings for the
behavioral and physiological dimensions were less consistent.
These results parallel known MT effects in adult recipients,
where multiple-dose reductions of depression and trait anxiety
are the largest effects.
In reviewing MT for pediatric recipients, we encountered
several weaknesses endemic to the MT research literature
that should be addressed in subsequent studies. These included
(i) low statistical power, (ii) frequent failure to report basic
descriptive statistics, (iii) descriptions of results that do not
logically follow study designs, and (iv) lack of replication.
We discuss these in turn.
Low statistical power. Most pediatric MT studies were
conducted with fewer than 30 participants. When studies are
this small, only the largest effects have any likelihood of being
uncovered. As researchers engaged in our own clinical MT
studies, we are sensitive to the expense and difficulty involved
in recruiting participants, but our empathy, unfortunately,
does nothing to change the mathematics of the situation.
The statistical power of MT studies must be increased
(primarily by conducting studies with larger samples) if we
wish to discover anything beyond the largest effects.
Failure to report basic descriptive statistics. Many pediatric
MT studies have appeared in journals with lax standards for
the reporting of data; there is no other explanation for why
studies would fail to report the most basic descriptive statistics.
When a report does not include the standard deviations that
describe the spread of the data, that report has almost no value
as scientific evidence. This must not be allowed to continue in
MT research, because it represents an enormous waste of
resources. Simply put, researchers who take the time, effort
and expense to perform a study should not allow the results of
that study to be published without the statistics that permit an
understanding of the outcome. If a journal does not require
them, then the onus is on the researcher to ensure that the
statistics are reported.
Results that do not logically follow study designs.
The importance of between-groups designs in MT has been
noted (12). Why, then, do so many MT studies that employ a
between-groups design emphasize within-group comparisons?
The likely answer is that planned between-groups comparisons
were non-significant (possibly due to low statistical power),
so study authors may given in to the temptation to report the
statistically significant, but misleading, within-group effect.
This problem is rampant in MT research, and represents a
real threat to the way this research will be perceived in the
future. Many of the consumers of MT research are committed
practitioners who have not had training in statistics and
research design (though it must be noted that research literacy
among MT practitioners is increasing). As such, they may be
inclined to believe that coming across the sacrosanct ‘P <
0.05’ is proof of an MT effect, without realizing that this
‘effect’ may be nothing more than the effect of time, a placebo
effect and/or regression to the mean. Knowledgeable con-
sumers of MT research must learn to distinguish within-group
effects from between-groups effects, and MT researchers must
clearly present between-groups findings when their studies
employ a between-groups design.
Lack of replication. All but two of the pediatric MT studies
we reviewed were conducted by the Touch Research Institute
at the University of Miami. Their contribution to MT research
has been considerable; however, scientific understanding is
hampered when one laboratory is responsible for almost all of
the results in an area of inquiry. Replication of results is
a foundation of scientific progress, so it is necessary that other
researchers contribute to this field. Given recent interest in
CAM modalities, the small number of studies from other
laboratories is surprising. We hope that this is about to change,
and the success of the recent Highlighting Massage Therapy in
CAM Research Conference (43) suggests that it will. Three
pediatric MT RCT’s from other research groups, currently in
progress, support our optimism. Two of these examine MT for
children and adolescents with cancer. While the results of
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outcomes from MT and heat therapy for terminal children (44)
cannot yet be reported, preliminary results of another study
examining anxiety, fatigue, pain and nausea outcomes from
MT in a sample of children with cancer (45) are promising; in
particular, reductions of anxiety are expected to be consistent
with what has been reported in this review. The third study,
conducted by the first author of this review (S.B.) and
researchers at the UCLA Pediatric Exercise Laboratory (46),
evaluates pre-exercise MT for children with and without heart
disease. Preliminary results show significant improvement in
VO2 (oxygen consumption) for children who have an MT
session prior to performing an exercise regimen on a stationary
bicycle.If these results are validated in final analyses,they will
be generally consistent with the finding that MT can improve
pulmonary function. There are two other studies worth
mentioning that have received IRB approval from Children’s
Memorial Hospital in Chicago and will be enrolling partici-
pants shortly. These studies are an evaluation of MT for
reduction of pain, nausea and anxiety in pediatric cancer
patients (47) and an evaluation of MT on immune function and
heart rate variability in HIV-infected pediatric patients (48).
The outcome measures for the first study are self-report
ratings of pain, nausea and anxiety, whereas the second study
evaluates T-Helper cells (CD4þ), T-Suppressor cells (CD8þ),
Total B cells (CD3,CD19),NaturalKiller cells (CD56þ), viral
load and heart rate variability.
Conclusion
Current research indicates that MT is not a panacea for
conditions studied in the pediatric population. In contrast to
what has sometimes been claimed, there is little to no evidence
to date to support effects such as improved immune system
functioning,reductionofspasticity,orameliorationofhostility.
In addition, there is currently scant evidence that MT provides
benefits by first reducing cortisol, as MT’s effect on this
stress hormone is seen to be small when analyzed correctly
(i.e. in between-groups as opposed to within-group compar-
isons). There is, however, a set of MT effects that have been
shown to have real value to the pediatric population. MT
shows a considerable impact on the state and trait anxiety
levels of children. Because these effects are strong, and also
because they are consistent with the findings in adults, future
research on the anxiolytic effects of MT on pediatric
recipients does not need to simply replicate previous studies.
The greatest progress can now be made by focusing on the
mediators and moderators of MT effects on anxiety, and on
testing explanatory theories of these outcomes. MT effects on
arthritispainandmuscletonealsoappeartobestrong,butthese
results do need to be replicated, as they are based on single
studies. Other pediatric outcomes that are promising, but in
need of further study, include MT’s effects on depression,
negative mood, certain types of behavior (likely due to
reductions of anxiety) and air flow in those suffering from
pulmonary disorders such as cystic fibrosis. As increased
statistical power in the form of additional studies is brought
to bear on these potential benefits, it is likely that some will
be quantitatively validated.
Finally, it has been noted that prior MT research has not
accounted for the communication that inevitably takes place
between massage therapists and their recipients, nor has it
examined the likelihood that therapists and recipients develop
a therapeutic relationship during the course of MT (10). This is
also true in pediatric MT studies. MT has important parallels
(in both process and outcomes) to psychotherapy (10), a
treatment that relies on communication and therapeutic
relationship to provide effects. It seems likely that MT effects,
especially those belonging to the affective category, are
mediated or moderated by these previously unexamined
factors. These should not be neglected in subsequent pediatric
MT research.
As adult consumers continue to explore and utilize all of
their health care options, children will increasingly be
recipients of MT. With this in mind, it is essential that we
continue to study the benefits of MT for children, and the
explanatory models that underlie them, so children’s health
and wellness can be maximized. The value of MT has been
examined for many specific conditions that afflict children. It
is our hope that this review has consolidated those findings,
indicated areas that require further study, and led to an
increased scientific understanding of pediatric MT.
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